Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_provenance.
• NP412782.RAz729gKR1bavkBD56_XU_KrJ_h7IEjQKEyvi1uKuHPaU130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412782.RAz729gKR1bavkBD56_XU_KrJ_h7IEjQKEyvi1uKuHPaU130_provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP802361.RAbLcD4pFvgdrFuJOE2Nqar__KA8ZUwomFOHV7XU_qiFM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802361.RAbLcD4pFvgdrFuJOE2Nqar__KA8ZUwomFOHV7XU_qiFM130_provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1373835.RASHqhpkdk8_EjflxtQaBGA8bDInoO4xzt1ruFxAxk1-4130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373835.RASHqhpkdk8_EjflxtQaBGA8bDInoO4xzt1ruFxAxk1-4130_provenance.
• NP1373833.RApiYjnAyMW-nZf5abfWOZXLwpP1WRp1l1Q79GPzNtFpM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373833.RApiYjnAyMW-nZf5abfWOZXLwpP1WRp1l1Q79GPzNtFpM130_provenance.
• NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940912.RAH2rZb_VlYuXYKMRDMRWmZ8OX0n8Cs2JGiuSmSzFvQvI130_provenance.
• NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373831.RAFm06OlVA6EmqJU5n7Yn9CsdB0iww1lG8GnqjsK0PNNM130_provenance.
• NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_provenance.
• NP1373827.RA-06XuP0Zt6PPc0ly1FxE4j_GzkTkG1M_LIKELdsqEe8130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373827.RA-06XuP0Zt6PPc0ly1FxE4j_GzkTkG1M_LIKELdsqEe8130_provenance.
• NP1373828.RAxDdz68_sUhGOvuaqOKue_6RhFJ1ooSSWzCiVGQoYltM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373828.RAxDdz68_sUhGOvuaqOKue_6RhFJ1ooSSWzCiVGQoYltM130_provenance.